SOGECLAIR (ALSOG.PA) Stock Fundamental Analysis

EPA:ALSOG • FR0000065864

32.7 EUR
+0.2 (+0.62%)
Last: Feb 24, 2026, 07:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ALSOG. ALSOG was compared to 51 industry peers in the Aerospace & Defense industry. ALSOG has an excellent financial health rating, but there are some minor concerns on its profitability. ALSOG may be a bit undervalued, certainly considering the very reasonable score on growth These ratings could make ALSOG a good candidate for value investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • ALSOG had positive earnings in the past year.
  • ALSOG had a positive operating cash flow in the past year.
  • Of the past 5 years ALSOG 4 years were profitable.
  • ALSOG had a positive operating cash flow in each of the past 5 years.
ALSOG.PA Yearly Net Income VS EBIT VS OCF VS FCFALSOG.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

  • With a Return On Assets value of 3.53%, ALSOG perfoms like the industry average, outperforming 47.06% of the companies in the same industry.
  • The Return On Equity of ALSOG (11.09%) is comparable to the rest of the industry.
  • The Return On Invested Capital of ALSOG (9.75%) is better than 62.75% of its industry peers.
  • ALSOG had an Average Return On Invested Capital over the past 3 years of 6.22%. This is below the industry average of 9.44%.
  • The last Return On Invested Capital (9.75%) for ALSOG is above the 3 year average (6.22%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.53%
ROE 11.09%
ROIC 9.75%
ROA(3y)2.07%
ROA(5y)-0.15%
ROE(3y)6.51%
ROE(5y)-1.92%
ROIC(3y)6.22%
ROIC(5y)N/A
ALSOG.PA Yearly ROA, ROE, ROICALSOG.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

  • With a Profit Margin value of 3.17%, ALSOG is not doing good in the industry: 62.75% of the companies in the same industry are doing better.
  • ALSOG's Profit Margin has improved in the last couple of years.
  • The Operating Margin of ALSOG (5.80%) is worse than 70.59% of its industry peers.
  • In the last couple of years the Operating Margin of ALSOG has grown nicely.
  • The Gross Margin of ALSOG (59.16%) is better than 88.24% of its industry peers.
  • ALSOG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.8%
PM (TTM) 3.17%
GM 59.16%
OM growth 3Y10.77%
OM growth 5YN/A
PM growth 3Y8.83%
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5YN/A
ALSOG.PA Yearly Profit, Operating, Gross MarginsALSOG.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40

7

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALSOG is creating some value.
  • ALSOG has about the same amout of shares outstanding than it did 1 year ago.
  • ALSOG has a better debt/assets ratio than last year.
ALSOG.PA Yearly Shares OutstandingALSOG.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 1M 2M 3M
ALSOG.PA Yearly Total Debt VS Total AssetsALSOG.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • ALSOG has an Altman-Z score of 2.64. This is not the best score and indicates that ALSOG is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ALSOG has a Altman-Z score (2.64) which is in line with its industry peers.
  • The Debt to FCF ratio of ALSOG is 1.39, which is an excellent value as it means it would take ALSOG, only 1.39 years of fcf income to pay off all of its debts.
  • ALSOG has a Debt to FCF ratio of 1.39. This is amongst the best in the industry. ALSOG outperforms 90.20% of its industry peers.
  • A Debt/Equity ratio of 0.44 indicates that ALSOG is not too dependend on debt financing.
  • ALSOG has a Debt to Equity ratio of 0.44. This is in the better half of the industry: ALSOG outperforms 60.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 1.39
Altman-Z 2.64
ROIC/WACC1.11
WACC8.75%
ALSOG.PA Yearly LT Debt VS Equity VS FCFALSOG.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

  • ALSOG has a Current Ratio of 1.66. This is a normal value and indicates that ALSOG is financially healthy and should not expect problems in meeting its short term obligations.
  • ALSOG has a better Current ratio (1.66) than 80.39% of its industry peers.
  • A Quick Ratio of 1.41 indicates that ALSOG should not have too much problems paying its short term obligations.
  • ALSOG has a better Quick ratio (1.41) than 84.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 1.41
ALSOG.PA Yearly Current Assets VS Current LiabilitesALSOG.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

  • ALSOG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.00%, which is quite impressive.
  • The Earnings Per Share has been growing by 18.82% on average over the past years. This is quite good.
  • The Revenue has been growing slightly by 2.53% in the past year.
  • The Revenue has been growing by 9.06% on average over the past years. This is quite good.
EPS 1Y (TTM)76%
EPS 3Y18.82%
EPS 5YN/A
EPS Q2Q%68.09%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y9.06%
Revenue growth 5YN/A
Sales Q2Q%1.85%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.42% on average over the next years. This is quite good.
  • Based on estimates for the next years, ALSOG will show a small growth in Revenue. The Revenue will grow by 6.01% on average per year.
EPS Next Y26.7%
EPS Next 2Y19.67%
EPS Next 3Y18.42%
EPS Next 5YN/A
Revenue Next Year7.59%
Revenue Next 2Y6.62%
Revenue Next 3Y6.01%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALSOG.PA Yearly Revenue VS EstimatesALSOG.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ALSOG.PA Yearly EPS VS EstimatesALSOG.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4 -6

8

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 19.82, the valuation of ALSOG can be described as rather expensive.
  • 100.00% of the companies in the same industry are more expensive than ALSOG, based on the Price/Earnings ratio.
  • ALSOG's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.98.
  • ALSOG is valuated correctly with a Price/Forward Earnings ratio of 12.60.
  • 100.00% of the companies in the same industry are more expensive than ALSOG, based on the Price/Forward Earnings ratio.
  • ALSOG is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.01, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.82
Fwd PE 12.6
ALSOG.PA Price Earnings VS Forward Price EarningsALSOG.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • 100.00% of the companies in the same industry are more expensive than ALSOG, based on the Enterprise Value to EBITDA ratio.
  • 100.00% of the companies in the same industry are more expensive than ALSOG, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.22
EV/EBITDA 9.12
ALSOG.PA Per share dataALSOG.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • ALSOG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of ALSOG may justify a higher PE ratio.
  • A more expensive valuation may be justified as ALSOG's earnings are expected to grow with 18.42% in the coming years.
PEG (NY)0.74
PEG (5Y)N/A
EPS Next 2Y19.67%
EPS Next 3Y18.42%

5

5. Dividend

5.1 Amount

  • ALSOG has a Yearly Dividend Yield of 3.20%.
  • ALSOG's Dividend Yield is rather good when compared to the industry average which is at 0.76. ALSOG pays more dividend than 100.00% of the companies in the same industry.
  • ALSOG's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 3.2%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
ALSOG.PA Yearly Dividends per shareALSOG.PA Yearly Dividends per shareYearly Dividends per share 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 58.56% of the earnings are spent on dividend by ALSOG. This is a bit on the high side, but may be sustainable.
DP58.56%
EPS Next 2Y19.67%
EPS Next 3Y18.42%
ALSOG.PA Yearly Income VS Free CF VS DividendALSOG.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 10M -10M 20M
ALSOG.PA Dividend Payout.ALSOG.PA Dividend Payout, showing the Payout Ratio.ALSOG.PA Dividend Payout.PayoutRetained Earnings

SOGECLAIR

EPA:ALSOG (2/24/2026, 7:00:00 PM)

32.7

+0.2 (+0.62%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)01-28
Earnings (Next)04-29
Inst Owners4.55%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap104.64M
Revenue(TTM)158.49M
Net Income(TTM)5.03M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.2%
Yearly Dividend0.94
Dividend Growth(5Y)N/A
DP58.56%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 19.82
Fwd PE 12.6
P/S 0.66
P/FCF 5.22
P/OCF 4.91
P/B 2.31
P/tB 4.26
EV/EBITDA 9.12
EPS(TTM)1.65
EY5.05%
EPS(NY)2.6
Fwd EY7.94%
FCF(TTM)6.26
FCFY19.15%
OCF(TTM)6.66
OCFY20.38%
SpS49.53
BVpS14.16
TBVpS7.68
PEG (NY)0.74
PEG (5Y)N/A
Graham Number22.93
Profitability
Industry RankSector Rank
ROA 3.53%
ROE 11.09%
ROCE 11.28%
ROIC 9.75%
ROICexc 12.05%
ROICexgc 17.44%
OM 5.8%
PM (TTM) 3.17%
GM 59.16%
FCFM 12.64%
ROA(3y)2.07%
ROA(5y)-0.15%
ROE(3y)6.51%
ROE(5y)-1.92%
ROIC(3y)6.22%
ROIC(5y)N/A
ROICexc(3y)7.41%
ROICexc(5y)N/A
ROICexgc(3y)10.8%
ROICexgc(5y)N/A
ROCE(3y)7.22%
ROCE(5y)N/A
ROICexgc growth 3Y2.87%
ROICexgc growth 5YN/A
ROICexc growth 3Y7.7%
ROICexc growth 5YN/A
OM growth 3Y10.77%
OM growth 5YN/A
PM growth 3Y8.83%
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5YN/A
F-Score8
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 1.39
Debt/EBITDA 1.61
Cap/Depr 38.36%
Cap/Sales 0.81%
Interest Coverage 9.7
Cash Conversion 169.91%
Profit Quality 398.63%
Current Ratio 1.66
Quick Ratio 1.41
Altman-Z 2.64
F-Score8
WACC8.75%
ROIC/WACC1.11
Cap/Depr(3y)47.93%
Cap/Depr(5y)229.26%
Cap/Sales(3y)2.07%
Cap/Sales(5y)2.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76%
EPS 3Y18.82%
EPS 5YN/A
EPS Q2Q%68.09%
EPS Next Y26.7%
EPS Next 2Y19.67%
EPS Next 3Y18.42%
EPS Next 5YN/A
Revenue 1Y (TTM)2.53%
Revenue growth 3Y9.06%
Revenue growth 5YN/A
Sales Q2Q%1.85%
Revenue Next Year7.59%
Revenue Next 2Y6.62%
Revenue Next 3Y6.01%
Revenue Next 5YN/A
EBIT growth 1Y48.67%
EBIT growth 3Y20.81%
EBIT growth 5YN/A
EBIT Next Year132.14%
EBIT Next 3Y38.24%
EBIT Next 5YN/A
FCF growth 1Y977.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y778.17%
OCF growth 3Y101.39%
OCF growth 5YN/A

SOGECLAIR / ALSOG.PA FAQ

What is the fundamental rating for ALSOG stock?

ChartMill assigns a fundamental rating of 6 / 10 to ALSOG.PA.


Can you provide the valuation status for SOGECLAIR?

ChartMill assigns a valuation rating of 8 / 10 to SOGECLAIR (ALSOG.PA). This can be considered as Undervalued.


What is the profitability of ALSOG stock?

SOGECLAIR (ALSOG.PA) has a profitability rating of 6 / 10.


What is the valuation of SOGECLAIR based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SOGECLAIR (ALSOG.PA) is 19.82 and the Price/Book (PB) ratio is 2.31.


Can you provide the dividend sustainability for ALSOG stock?

The dividend rating of SOGECLAIR (ALSOG.PA) is 5 / 10 and the dividend payout ratio is 58.56%.